[By NBC-1TV H. J Yook]Mayapada Hospital South Jakarta performed its first ever laparoscopic surgery to remove fibroids from a woman's body on Wednesday, June 12th. The successful surgery was performed by a team of medical experts led by Dr. Setyo Hermanto, SpOG. The patient, a woman aged 39, Mrs. Suliyem, came with a complaint of uterine myomas (fibroids). “The patient had fibroids weighing more than two pounds. After conducting a thorough examination and a review of her health record, we and her family decided to remove the fibroids through a Total Laparoscopic Hysterectomy (TLH) surgery. All
[NBC-1TV 김종우 기자]"우리 피자 맛있다고 하시는 손님들 보면 제일 행복해요" 폭염이 기승을 부린 15일 오후, 독특한 피자 맛에 이끌려 주문대 앞에 줄지어 선 손님들을 상대하는 이상곤(53. 피자마루 대전 중촌 . 목동점) 사장의 표정이 유난히 밝다.체감 온도가 40도에 육박하는 조리실에서 전화 주문을 받는 부인 박운순 씨와 종업원 김지선(23 대전 보건대 2학년)양의 표정도 예외가 아니다. 지난 2009년 9월 3일 개업한 후 입소문을 타고 유명세를 타고 있는 이상곤 사장의 매장과 조리실을 NBC-1TV가 스케치 해 보았다.
[By NBC-1TV H. J Yook]New guidelines released by the Thalassaemia International Federation (TIF) address the Management of Non-Transfusion Dependent Thalassaemias (NTDT) and are a first of their kind in the field of medical haematology. The guidelines, presented today at the 18th Congress of the European Haematology Association (EHA), provide a consensus of international expert opinion based on the latest data in the field, and were developed to give clinicians easy-to-follow protocols to better identify and manage this patient population, who are often overlooked or under-diagnosed. NTDT is a
[NBC-1TV H. J Yook]NANOBIOTIX (Euronext: NANO), a clinical-stage nanomedicine company pioneering novel approaches for the local treatment of cancer, announces today that its lead compound NBTXR3 has received authorization from the French Medicine Agency, ANSM[1], to start a clinical trial in patients with locally advanced cancers of the oral cavity or oropharynx (head and neck cancer), at the Institut Curie, Paris, France, a French leading cancer treatment center. This represents a second indication for NBTXR3 which is also in clinical trials for soft tissue sarcoma. The phase I trial will be
[By NBC-1TV H. J Yook]Dunbar Digital Armor, the cyber security affiliate of Dunbar Armored, Inc. has announced that it has begun providing services to the NASDAQ OMX Group to protect access to FinQloud, the company‘s secure, cloud computing platform designed exclusively for the financial services industry. Dunbar Digital Armor will support FinQloud’s Regulatory Record Retention (R3) storage solution which provides broker dealers with the ability to safely meet record archival and retrieval requirements at substantially reduced cost and complexity. “Dunbar Digital Armor is proud to be a trusted
[By NBC-1TV H. J Yook]Infinera (NASDAQ: INFN) announced today the Infinera Intelligent Transport Network™, an architecture for carriers to exploit the increasing demand for cloud-based services and data center connectivity as they advance into the Terabit Era. The Terabit Era envisions a highly connected global community sharing experiences and doing business at light speed, delivered by an infinite pool of intelligent bandwidth. The Intelligent Transport Network helps carriers use time as a weapon to increase revenues with reliable, differentiated services while reducing operating costs throu
[By NBC-1TV H. J Yook]According to a recent SolarWinds survey* of over 160 IT professionals, the No. 1 security concern and priority is data loss and the prevention of that data loss. SolarWinds (NYSE: SWI), a leading provider of powerful and affordable IT management software, today announced the availability of SolarWinds Log & Event Manager (LEM) Workstation Edition, which can help manage data loss on Microsoft® Windows® workstations at an affordable price for all IT professionals. SolarWinds LEM Workstation Edition supports log management, correlation and analysis from Windows workstations
[By NBC-1TV H. J Yook]IncellDx announced today that it has executed an agreement with Kindstar Global, the largest esoteric diagnostic testing service in China, to offer its proprietary laboratory test for the detection of oncogenic HPV E6, E7 mRNA in China. According to the Company, it believes that this agreement will greatly augment its business presence in Asia. This test is based upon IncellDx‘s advanced molecular diagnostic technology for quantifying specific biomarkers that have been associated with an increased risk of progression to cervical cancer, and will broaden Kindstar’s current